HIGHLY SAFE NON-LAMELLAR LIQUID CRYSTAL FORMING COMPOSITION

The present invention provides a highly safe non-lamellar liquid crystal-forming composition. The present invention relates to a non-lamellar liquid crystal-forming composition comprising a phospholipid and an amphipathic compound represented by the following general formula (I), wherein X and Y each denotes a hydrogen atom or together denote an oxygen atom, n denotes the integer 1 or 2, m denotes the integer 1 or 2, and R denotes a hydrophilic group having one or more hydroxyl groups, and wherein the composition has an increased biocompatibility by the phospholipid..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 20. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

TABATA YASUHIKO [VerfasserIn]
MURAKAMI TAKAHIDE [VerfasserIn]
TODO HIROAKI [VerfasserIn]
ITAKURA SHOKO [VerfasserIn]
SUGIBAYASHI KENJI [VerfasserIn]
HIJIKURO ICHIRO [VerfasserIn]
TANOMURA MASAHISA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07C: Acyclic or carbocyclic compounds (macromolecular co (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-20, Last update posted on www.tib.eu: 2024-04-02, Last updated: 2024-04-09

Patentnummer:

EP4098281

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA002834707